BioSpace News Archive

Drug Development

Candel Therapeutics Presents Preclinical Data from its enLIGHTEN™ Discovery Platform at SITC

Candel Therapeutics, Inc. will present two posters during the 2023 Society for Immunotherapy of Cancer Annual Meeting in San Diego focused on the enLIGHTEN™ Discovery Platform.

November 4, 2023
·
8 min read
Drug Development

Vera Therapeutics Presents Positive Data from Phase 2b ORIGIN Study Showing Resolution of Hematuria in Majority of Patients at the American Society of Nephrology Kidney Week 2023

Vera Therapeutics, Inc. announced the presentation of three posters – including an additional analysis of week 36 data from the Phase 2b ORIGIN study demonstrating resolution of hematuria in the majority of patients – on the Company’s product candidate atacicept in patients with immunoglobulin A nephropathy at the American Society of Nephrology Kidney Week 2023, in Philadelphia, PA.

November 4, 2023
·
9 min read
Job Trends

IZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years

Astellas Pharma Inc. announced results from the GATHER2 Phase 3 clinical trial, demonstrating IZERVAY™ continued to reduce the rate of geographic atrophy lesion growth for both every month and every-other-month dosing vs. sham through 2 years of treatment in patients with GA secondary to age-related macular degeneration.

November 4, 2023
·
8 min read